Functional annotation of the PRRX1 signature genes revealed a strong association with immune-related genes and processes, displaying both antitumor (Th1) and tumor-tolerant (Th2) responses, which was consistent with the predicted enrichment of immune cells in the PRRX1high subgroup. Here, PRRX1 is linked to neoplasm.